SANUWAVE Health, Inc. (SNWV)
Healthcare
Medical Devices
6.20 $
-1.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns SANUWAVE Health, Inc. (SNWV)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 67.3% of the shares are freely tradable; institutional investors hold 47.2%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
47.2%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
1.3%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
67.3%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
13.5%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
9Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Opaleye Management Inc | 11.41 | 981,267 | +0.0 | 03/31/2026 |
| BlackRock Inc | 5.60 | 481,540 | -1.8 | 03/31/2026 |
| Awm Investment Company Inc | 5.29 | 454,550 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 5.18 | 445,206 | +1.1 | 12/31/2025 |
| Praetorian PR LLC | 4.07 | 350,000 | +32.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.06 | 348,874 | +0.0 | 03/31/2026 |
| Solas Capital Management LLC | 3.34 | 287,514 | -2.0 | 03/31/2026 |
| Stifel Financial Corp | 2.93 | 251,633 | +41.9 | 03/31/2026 |
| UBS Group AG | 2.45 | 210,263 | +1,029.2 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.08 | 264,933 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.